| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |